Linked Life Data

11889788

Source:http://linkedlifedata.com/resource/pubmed/id/11889788

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-3-13
pubmed:abstractText
Precise management of blood pressure and heart rate is required during minimally invasive direct coronary artery bypass (MIDCAB). Previously, low dose diltiazem and beta-blokers have been employed for control of circulation during this procedure, but we report 2 patients whose blood pressure and heart rate were managed during MIDCAB by high-dose diltiazem. In both patients, anesthesia was induced with propofol, vecuronium and fentanyl, and maintained by continuous infusion of propofol and inhalation of oxygen and nitrous oxide. Fentanyl, midazolam, and sevoflurane were administered occasionally. Immediately after the induction, a continuous infusion of nicorandil (2 to 4 mg.hr-1) was started and diltiazem (4 to 15 micrograms.kg-1.min-1) was administered continuously from the beginning of the surgery. Following discontinuation of diltiazem administration, blood pressure and heart rate returned to their preoperative values. These results suggest that safe anesthetic management during MIDCAB can be performed with highdose diltiazem.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0021-4892
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
177-81
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Anesthetic management of MIDCAB with high dose diltiazem].
pubmed:affiliation
Department of Anesthesia, Toyoko Hospital, St. Marianna University School of Medicine, Kawasaki 211-0063.
pubmed:publicationType
Journal Article, English Abstract, Case Reports